End-to-End Clinical Trial Supply Chain Management
GH Strategies provides end-to-end clinical trial supply chain management across South Africa, combining operational oversight with SAHPRA-aligned regulatory expertise.
What We Offer
Clinical Trial Site Supply Coordination
Coordinating product supply, returns, and destruction with trial sites to ensure accountability and regulatory alignment.
Import and Export Permit Management
Preparation, submission, and follow-up of SAHPRA and port authority applications for seamless import and export of trial products.
Cold Chain Oversight and Monitoring
End-to-end temperature control solutions for biologics, vaccines, and sensitive products to maintain product quality and compliance.
GxP Vendor Qualification and Oversight
Auditing, qualifying, and monitoring local and international vendors to ensure adherence to GxP and sponsor requirements.
Clinical Supply Chain Risk Assessments
Identifying and mitigating risks across supply chain nodes, from manufacturing to site delivery.
Customs and Logistics Compliance
Navigating customs clearance processes and ensuring compliance with local and international shipping regulations.
Is Your Clinical Supply Chain Risk-Free?
Speak to an Expert.
Benefits of Partnering GH Strategies
Reliable Compliance
Risk Reduction
Operational Efficiency

How We Work
Our work is driven by clarity, discipline, and a commitment to excellence. We integrate operational precision with clinical and regulatory insight to keep your trial moving efficiently and confidently.
Frequently Asked Questions (FAQs)
Clinical operations include the planning, execution, monitoring, and oversight of clinical trials to ensure regulatory compliance, patient safety, accurate data collection, and adherence to ICH GCP. GH Strategies supports trial sponsors and research organisations with site management, protocol implementation, and operational oversight across African regions.
Clinical trial supply chain management includes forecasting, drug ordering, temperature-controlled storage, distribution, import/export permitting, packaging, labelling, and end-of-study drug accountability. GH Strategies manages end-to-end trial logistics, ensuring product integrity from manufacturer to site.
We prepare and submit import/export permit applications, compile supporting documents, liaise with licensed depots and couriers, and ensure all regulatory and customs requirements are met. Our process reduces delays and ensures compliant transport of investigational products, controlled substances, and biological samples.
Most investigational products require controlled temperatures to maintain stability and efficacy. Deviations can invalidate product batches or compromise patient safety. GH Strategies implements validated temperature monitoring systems, deviation management processes, and root-cause analysis to protect product integrity throughout the supply chain.
Vendor oversight involves monitoring the performance, quality, and compliance of third-party service providers such as depots, couriers, laboratories, and CROs. GH Strategies provides structured oversight through KPIs, audits, quality agreements, and compliance reviews, ensuring vendors meet ICH GCP, SAHPRA, and sponsor expectations.
We support sites with protocol training, documentation management, safety reporting processes, informed consent guidance, monitoring support, and audit readiness. Our team ensures trial activities remain aligned with ICH GCP, sponsor requirements, and national regulatory standards throughout the study lifecycle.
From the Newsroom

Launching the GH Strategies Institute: Empowering Pharma and MedTech Professionals Through e-Learning
There are moments in every industry when progress demands a new way of thinking. For…

Strengthening Pharmacovigilance Systems: GH Strategies’ Vision for Safer Healthcare
Every medicine, vaccine, and medical device carries the promise of better health, but also the…

SAHPRA Requires ISO 13485 Certification for Medical Device Establishment Licences in South Africa
In April 2025, the South African Health Products Regulatory Authority (SAHPRA) formally announced that medical…

Optimising the Clinical Supply Chain: GH Strategies’ Role in Global Trial Readiness from South Africa
Clinical trials depend on precision – not only in research design but also in how…
Let’s Discuss Your Next Project
Partner with GH Strategies to build stronger, simpler, and smarter compliance systems that work.

